A new experimental diabetes jab, retatrutide, has shown promising Phase-3 trial results, helping type 2 diabetes patients ...

ACHIEVE-5 tested the oral GLP-1 drug in combination with a basal insulin regimen ...

Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide), today announced detailed results from three Phase 3 ...

HDV-Insulin Lispro (HDV-LIS) met A1C non-inferiority at Weeks 12 and 25, confirming comparable glycemic control to insulin lispro (LIS) with point-estimate differences below FDA-required 0.1% ...

Backed by a meta-analysis of over 4,300 patients, once-weekly tirzepatide slashes blood sugar, weight, and cardiovascular risks more effectively than daily insulin, offering a groundbreaking ...

Wearable mobile health technology could help people with Type 2 Diabetes (T2D) to stick to exercise regimes that help them to keep the condition under control, a new study reveals. An international ...

For millions of Americans, diabetes can be a daily struggle, and for the state of Kentucky, diabetes has been a challenge ...

Adequately treating diabetes demands an array of considerations and therapy strategies. Yehuda Handelsman, MD, FACP, FNLA, FASPC, MACE: The contemporary approach to managing diabetes is not only to ...

SAN ANTONIO – It may not be a total cure for diabetes, but the largest, randomized clinical trial for a “bionic pancreas” in San Antonio resulted in what may be the best effortless control of the ...

University of Utah Department of Pediatrics provides rate of birth defects from uncontrolled diabetes in pregnancy Birth defects affect 1 in 33 pregnancies in Utah. January is National Birth Defects ...

Dihydropyridine calcium-channel-blockers (DCCBs), used to treat high blood pressure, could speed up the progression of kidney ...

More than 10% of Americans have diabetes and roughly half of us are at risk for the disease, but most don't know how to eat to prevent the worst outcomes. To some degree, the advice is the same ...